Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
BioMedix® Launches Enhanced Non-Invasive Vascular Testing Devices, PADnet® and VEINnet™

ST. PAUL, Minn., Dec. 18, 2012 /PRNewswire/ -- BioMedix, a leader in healthcare IT designed to help manage disease and optimize medical practices, today introduced exciting technology for non-invasive vascular testing. The next generation of the BioMedix flagship device, PADnet, and the new VEINnet device deliver expanded vascular testing capabilities and added clinical value while remaining remarkably user friendly.

Vascular diseases, including Peripheral Artery Disease (PAD) and Chronic Venous Insufficiency (CVI), affect millions of Americans and can be life-threatening if not detected. PAD involves poor circulation in the limbs due to narrowing of the arteries as a result of plaque buildup and hardening of the arteries (atherosclerosis).  PAD increases risk for heart attack, stroke and amputation. CVI is a common cause of leg pain and swelling that occurs when the valves of the veins do not function properly and circulation of blood in the leg veins is impaired. CVI may be an indicator of blood clots in the deep veins of the legs, and can lead to venous hypertension and ulceration.1

PAD and CVI can be treated effectively if detected early. PADnet provides non-invasive testing for PAD in just 15 to 20 minutes and is Doppler enabled to allow external Doppler device input. VEINnet facilitates early detection of CVI and proximal venous obstruction in as little as 15 minutes.

"The next generation PADnet and the new VEINnet represent exciting steps forward in BioMedix vascular testing technology," said David Lerner, BioMedix Vice President of R & D and CTO. "These devices continue to enable greater access to vascular disease testing in non-interventional settings, meaning that more patients with disease can be found before disease progresses to a potentially critical stage."

PADnet detects PAD with Ankle-Brachial Index, Toe-Brachial Index and Pulse Volume Recording capabilities, including Post-Exercise testing and Segmental Pressures testing. VEINnet offers multi-method venous refill tests to identify venous insufficiency and venous outflow testing to help determine the presence of proximal venous obstruction. PADnet and VEINnet support the effective detection of vascular disease, even in patients with advanced disease. The tests are clinically valuable and provide fair financial return with medically-appropriate testing.

The devices send test data to a remote specialist for web-based interpretation, providing a platform that encourages collaborative care and improved outcomes. VEINnet and PADnet systems seamlessly integrate with the complete suite of BioMedix disease management and practice optimization products and services, creating a comprehensive solution.

"We are thrilled to introduce new technology with the power to expand the collaborative care network of healthcare professionals who are working to save limbs and lives through coordinated patient care," said John Romans, BioMedix President & CEO.

About BioMedix

BioMedix is a leader in healthcare IT designed to build and support community-based collaborative healthcare networks. BioMedix solutions coordinate the identification, treatment and management of patients with vascular disease while optimizing provider resources with cloud- and premise-based tools and integrated services. For more information about BioMedix, PADnet and VEINnet, call 877-854-0014 or visit www.BioMedix.com.

1. Vascular Disease Foundation. (2012.) http://vasculardisease.org. / Reference: ML-043, ML-188

 

SOURCE BioMedix

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
The BPM world is going through some evolution or changes where traditional business process management solutions really have nowhere to go in terms of development of the road map. In this demo at 15th Cloud Expo, Kyle Hansen, Director of Professional Services at AgilePoint, shows...
The move in recent years to cloud computing services and architectures has added significant pace to the application development and deployment environment. When enterprise IT can spin up large computing instances in just minutes, developers can also design and deploy in small ti...
Verizon Enterprise Solutions is simplifying the cloud-purchasing experience for its clients, with the launch of Verizon Cloud Marketplace, a key foundational component of the company's robust ecosystem of enterprise-class technologies. The online storefront will initially feature...
AppZero has announced that its award-winning application migration software is now fully qualified within the Microsoft Azure Certified program. AppZero has undergone extensive technical evaluation with Microsoft Corp., earning its designation as Microsoft Azure Certified. As a r...
“In the past year we've seen a lot of stabilization of WebRTC. You can now use it in production with a far greater degree of certainty. A lot of the real developments in the past year have been in things like the data channel, which will enable a whole new type of application," e...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE